Camp4 Therapeutics (CAMP) Return on Capital Employed (2024 - 2026)

Camp4 Therapeutics (CAMP) has 3 years of Return on Capital Employed data on file, last reported at 55.29% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 2789.0% year-over-year to 55.29%; the trailing twelve-month figure through Mar 2026 stood at 55.29% (up 2789.0% YoY), and the FY2025 full-year result was 63.67%, up 2942.0% from the prior year.
• Return on Capital Employed advanced to 55.29% in Q1 2026, from 60.7% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 55.29% in Q1 2026 to a low of 131.93% in Q4 2024.
• A 3-year average of 87.91% and a median of 85.74% in 2025 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed surged 7124 bps in 2025 and soared 2789 bps in 2026, its largest moves.
• Tracing CAMP's Return on Capital Employed over 3 years: stood at 131.93% in 2024, then soared by 54 bps to 60.7% in 2025, then climbed by 9 bps to 55.29% in 2026.
• Business Quant data shows CAMP's Return on Capital Employed at 55.29% in Q1 2026, 60.7% in Q4 2025, and 88.32% in Q3 2025.